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Microalgae accumulate lipids during stress such as that of nutrient deprivation, concomitant with cessation of growth
and depletion of chloroplasts. By contrast, certain small chemical compounds selected by high-throughput screening in
Chlamydomonas reinhardtii can induce lipid accumulation during growth, maintaining biomass. Comprehensive pathway
analyses using proteomics, transcriptomics, and metabolomics data were acquired from Chlamydomonas cells grown in the
presence of one of two structurally distinct lipid activators. WD10784 stimulates both starch and lipid accumulation,
whereas WD30030-treated cells accumulate only lipids. The differences in starch accumulation are largely due to
differential effects of the two compounds on substrate levels that feed into starch synthesis and on genes encoding
starch metabolic enzymes. The compounds had differential effects on photosynthesis, respiration, and oxidative stress
pathways. Cells treated with WD10784 showed slowed growth over time and reduced abundance of photosynthetic
proteins, decreased respiration, and increased oxidative stress proteins, glutathione, and reactive oxygen species specific
to this compound. Both compounds maintained central carbon and nitrogen metabolism, including the tricarboxylic acid
cycle, glycolysis, respiration, and the Calvin–Benson–Bassham cycle. There were few changes in proteins and transcripts
related to fatty acid biosynthesis, whereas proteins and transcripts for triglyceride production were elevated, suggesting
that lipid synthesis is largely driven by substrate availability. This study reports that the compound WD30030 and, to a
lesser extent WD10784, increases lipid and lipid droplet synthesis and storage without restricting growth or biomass
accumulation by mechanisms that are substantially different from nutrient deprivation.
Green algae hold great promise as a feedstock for
biofuel production due to their ability to synthesize and
store triacylglycerides (TAGs) in lipid droplets (LDs;
Guschina and Harwood, 2006; Li-Beisson et al., 2019).
However, the relatively low lipid accumulation per unit
biomass produced in standard growth conditions has
rendered them economically impractical for biofuel
production (Wijffels and Barbosa, 2010). Therefore,
much effort has gone into devising methods to in-
crease both biomass and lipid yield, and to reduce
the induction of stress response pathways. The uni-
cellular green alga Chlamydomonas reinhardtii has
emerged as a valuable model system to study both
photosynthesis and metabolic processes that are im-
portant for the biological production of economically
valuable products. The annotated genome sequence
in Phytozome facilitates gene-based comparative stud-
ies to understand lipid biochemistry. Although several
strategies have been attempted to improve lipid pro-
duction, such as targeted strain design and improve-
ments in growth and harvesting techniques, in most
cases the green algae accumulate lipids only when
subjected to severe stresses such as nutrient deple-
tion, particularly nitrogen starvation (Wang et al.,
2009; Miller et al., 2010; Schmollinger et al., 2014).
However, nutrient starvation arrests growth, which
is disadvantageous for large-scale production. There-
fore, to improve lipid yield for biofuel production, it is
important to design methods to decouple lipid accu-
mulation from growth arrest.
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Numerous previous studies have examined lipid
accumulation in green algae for cells grown under a
variety of stressors such as nitrogen, sulfur, phospho-
rus, or iron deprivation (Wang et al., 2009; Miller et al.,
2010; Nguyen et al., 2011; Lee et al., 2012; Blaby et al.,
2013; Schmollinger et al., 2014; Wase et al., 2014; Ajjawi
et al., 2017). A subset of these studies employed data-
rich omics technologies to identify key alterations in
expression of metabolic networks or regulatory com-
ponents that might contribute to lipid production
(Boyle et al., 2012; Blaby et al., 2013; Goodenough et al.,
2014; Schmollinger et al., 2014; Wase et al., 2014; Ajjawi
et al., 2017; Gargouri et al., 2017). Classical hallmarks of
nitrogen starvation include downregulation of protein
synthesis, degradation of the photosynthetic appara-
tus, and the movement of primary carbon into long-
term storage molecules as starch and TAGs (Blaby
et al., 2013; Alboresi et al., 2016). This is correlated
with increased expression of diglyceride acyltrans-
ferase (DGTT1) and the major lipid droplet protein
(MLDP). However, it is unclear if these factors and
processes are necessary to induce lipid accumulation
or are merely expressed coincident with the nutrient
deprivation response.
A novel approach to increase lipid yield is to select
chemical inducers of TAG production during photo-
trophic or mixotrophic growth conditions (for review,
see Wase et al., 2018). Franz et al. (2013) employed
microplate-based phenotypic screening of a small li-
brary of bioactive molecules (;50) in four strains of
oleaginous microalgae (Nannochloropsis salina, Nanno-
chloropsis oculata, Nannochloris sp, and Phaeodactylum
tricornutum) to select compounds that increased lipid
accumulation by at least 2-fold without terminating
growth.Among the hits were forskolin, which in-
creases cAMP levels, and quinacrine, which inhibits
NF-kB and facilitates p53 activator, in mammalian
systems. A similar study identified the MAP kinase
inhibitor U0126 (Promega) and another cAMP mod-
ulator IBMX (cat. no. I5879; Sigma-Aldrich) in Chla-
mydomonas (Choi et al., 2015).
Although counterintuitive, compounds known to
inhibit important enzymes of fatty acid (FA) and glyc-
erolipid biosynthesis were also found to increase stor-
age lipids including the fop herbicides thiolactomycin,
cerulenin, and triclosan. The fop herbicides inhibit cy-
tosolic acetyl-CoA carboxylase (Xiang et al., 2009),
whereas cerulenin and triclosan inhibit the type-II FA,
synthase (Chevalier et al., 2016). Thus, in these cases,
induction of storage lipids ismost likely due to turnover
of other lipid species as de novo synthesis is inhibited.
The inhibitor of Arabidopsis (Arabidopsis thaliana)
monogalactosyldiacylglycerol synthase Galvestine-
1 was identified using a similar screening effort (Botté
et al., 2011), again suggesting inhibition of one arm of
lipid synthesis funnels substrates or metabolites into
different complex lipid species.
The most comprehensive high throughput screen
for lipid-inducing compounds during algal growth in
the absence of stress conditions such as nutrient
deprivation was conducted by this laboratory using
Chlamydomonas (Wase et al., 2017). More than 43,000
compounds were screened, and 243 active compounds
were identified and verified using dose-response
curves to estimate lipid accumulation levels during
growth. Among the primary hits were two compounds
called “WD10784” and “WD30030,”which represented
two different chemical structural classes that act to
increase lipid storage in algae. Secondary screens con-
firmed both compounds increased lipid storage 4- to
5-fold over 72 h of compound treatment in a dose-
dependent manner. Importantly, lipid induction also
occurred during growth in three additional freshwa-
ter algae including Chlorella vulgarisUTEX395, Chlorella
sorokinianaUTEX1230, andTetrachlorella alternsUTEX2453
(Wase et al., 2017). The two compounds induced both
similar and unique profiles regarding cellular physiology
and metabolism. Briefly, both induced FA and triglyc-
eride accumulation without altering galactolipid levels
(Wase et al., 2017). WD30030 did not influence starch
storage, whereas WD10784 increased starch 2.5-fold.
Additionally, the WD10784 compound reduced chlo-
rophyll (Chl) a and b levels and total carotenoids and
the WD30030 compound did not affect these pigments.
In this work, proteomics, transcriptomics, and metab-
olomics profiling were conducted to provide further
insight into pathway adjustments leading to lipid syn-
thesis and storage induced by these two compounds.
The goal of this work was to define similarities and
differences between each compound and to contrast
the mechanistic impact of the compounds on cellular
physiology and biochemistry, particularly in com-
parison with well-characterized abiotic stress condi-
tions, such as nitrogen deprivation, which have been
used extensively to increase lipid synthesis and storage.
Importantly, this work supports and extends previous
studies demonstrating that cells treated with WD30030
maintain proteins involved in photosynthesis, protein
synthesis, and central carbon metabolism that support
growth and lipid synthesis. In contrast, treatment of
cells with WD10784 after 48 h in culture, induced
some stress response pathways and resulted in limited
chlorosis. Thus, WD30030 in particular represents an
important reagent in our arsenal to provide economi-
cally feasible biofuel feedstocks and other high-value
products.
RESULTS
Comparative Proteomics, Transcriptomics, and
Metabolomics of Chlamydomonas after Treatment with
WD30030 or WD10784
WD30030 and WD10784 were identified in a high
throughput screen that selected compounds that in-
creased triglyceride accumulation during growth (Wase
et al., 2017). The core structures of the compounds are
different, and each represents the most potent in induc-
ing lipid accumulation among that compound class.
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Each passed secondary screens that confirmed the
growth and lipid phenotypes but also distinguished the
impact of the two compounds in terms of levels of starch,
Glc, specific amino acids, and tricarboxylic acid cycle
intermediates. This study was carried out to further
understand and contrast the impacts of WD30030 and
WD10784 on algal metabolism leading to lipid produc-
tion and storage using a multiomics approach as has
proven effective to understand biochemical and physi-
ological shifts that occur in nutrient deprivation condi-
tions (Blaby et al., 2013; Schmollinger et al., 2014; Wase
et al., 2014; Park et al., 2015). Our ultimate goal is to
find the most effective reagent for maximizing lipid
storage without inducing stress responses or limiting
biomass yield.
We compared the response of Chlamydomonas to
treatment with each compound at a final concentration
of 5 mM, which approximates the concentration at
which a half-maximal response (i.e. lipid accumulation)
occurs (EC50; Fig. 1A). The compounds were added to
a single well containing 500,000 cells in 200 mL of cul-
ture media (;OD600 0.15) and growth was continued
for up to 72 h. Estimates of dry weight showed that
compound-treated cells accumulated approximately
the same dry cell mass as controls for up to 48 h, af-
ter which growth slows and differences between
compound-treated and controls become discernible
(Fig. 1B). Lipid accumulation is increased to 3-fold in
the first 24 hours of growth after treatment and con-
tinues to accumulate over 72 h (Fig. 1C). From these
data, it is also apparent that compound WD30030
promotes higher lipid accumulation and higher bio-
mass accumulation compared with WD10784. These
results further demonstrate lipid accumulation can be
induced to high levels without introducing a severe
stress that rapidly leads to growth termination as oc-
curs during nutrient limitation (Hu et al., 2008) or in
response to previously identified chemical inducers of
TAG accumulation including Brefeldin A and fenpro-
pimorph (Kim et al., 2015;Wase et al., 2015). Employing
these data, triplicate cultures were treated with the
compounds, harvested after 72 h, and then pro-
teins, RNA, and metabolites were prepared for global
screening and comparison with untreated control cul-
tures as detailed in “Materials and Methods” and il-
lustrated in Figure 2. The data were then compared to
provide mechanistic insight into metabolic and regu-
latory changes that lead to lipid storage.
Label-free comparative proteomics was applied to
three biological replicates for each compound treatment
and independently compared to the control sample. A
total of 45,384 features comprising charges of 21, 31,
and 41 were identified. Of these, 8,590 features were
assigned to specific peptide matches by an MSE search
resulting in identification and quantification of 884
proteins across all sample groups (Supplemental Dataset
S1). Differentially abundant proteins were identified and
analyzed to compare the concordance and differences in
protein abundance for those significantly changed after
compound treatment (Tables 1 and 2; Supplemental Fig.
S1). Differentially abundant proteins were defined by a
log2-fold change (log2FC). 0.5 or,20.5 with a P value
# 0.05. In the subset of proteins with increased abun-
dance, 63 were unique to the WD10784 treatment and
23 proteins were unique to the WD30030 treatment,
whereas 123 were shared between the two treatments.
Similarly, 69 proteins with reduced abundance rela-
tive to controls were unique to compound WD10784,
whereas 23 proteinswere unique to compoundWD30030
treatment, and 48 proteins were shared between the two
treatment conditions. Enriched pathway clusters were
generated from the data resulting in identification of 13
that were significantly altered after WD10784 treat-
ment and 11 after WD30030 treatment. There was more
concordance between the two compound treatments
for proteins that increased in abundance in the pathway
Figure 1. Estimates of lipid accumulation and biomass after compound treatment. A, Log dose response curves with varying
concentrations of compounds by comparisonwith controls (vehicle alone). B, Biomass estimated as dry cell weight over time at 5
mM of compound or vehicle alone (Control) as indicated. C, Estimation of lipid concentration in cells over time after compound
treatment; n5 3 biological replicates, error bars indicate mean6 SE. Twoway-ANOVAwith Bonferroni posttest was performed to
determine significant differences between compound treatment and controls over time. Statistical significance is indicated by
*P # 0.05 , **P # 0.01, ***P # 0.001.
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clusters of carbon metabolism, biosynthesis of second-
ary metabolites, and amino acid and sugar metabolism
compared to those that were reduced. In this case,
WD10784 decreased abundance of some proteins that
mapped to carbon fixation, synthesis of secondary
metabolites, pyruvate metabolism, and the pentose P
pathway, whereas WD30030 did not.
To assess compound impacts on gene expression,
whole transcriptome sequencing by RNA sequenc-
ing (RNA-Seq) was performed. From a total of 15,965
mapped genes, 1,816 differentially expressed genes
(DEGs; log2FC. 2 or,22 and P# 0.01) were detected
with compound WD30030 treatment (Supplemental
Dataset S2; Supplemental Fig. S2), of which 910 were
significantly increased, whereas 926were decreased. By
comparison, compound WD10784 treatment resulted
in a total of 4,364 transcripts significantly different from
controls of which 2,266 were increased, whereas 2,098
transcripts were decreased. Of these, 722 transcripts
were upregulated by both compounds and 664 were
reduced by both compound treatments. These data
indicated a more pronounced impact of WD10784
treatment on transcription by comparisonwithWD30030.
Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway enrichment analysis of the DEGs with re-
duced abundance from WD30030-treated cells showed
enrichment in only three categories including ribo-
somes, photosynthesis, and photosynthetic antenna
proteins, whereas transcripts with increased expression
mapped to nine categories, the most abundant of which
were genes involved in DNA replication, purine me-
tabolism, and protein processing in the endoplasmic
reticulum (ER; Supplemental Fig. S3). Treatment with
compoundWD10784 had a pronounced effect on genes
in 25 metabolic pathways. Most of the transcripts with
decreased expression were in the categories “ribo-
somes,” “biosynthesis of secondarymetabolites,” “carbon
metabolism,” and “photosynthesis and photosynthetic
antenna proteins,” whereas transcripts with increased
expression were distributed in the categories “DNA rep-
lication” and “glutathione (GSH) metabolism,” and
others related primarily to lipid and carbon metabolism.
Figure 2. Outline of the workflow adopted for multiomics experiments to characterize the metabolic changes induced by lipid
activators in Chlamydomonas. NGS, Next-Generation Sequencing, PLGS-MSE, ProteinLynx Global SERVER (Waters Corp),
XCMS, https://bioconductor.org/packages/release/bioc/.
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Table 1. Selected proteins with increased abundance after compound treatment (from Supplemental Datasets S1 and S5–S13)
Significant fold change and P values are indicated in bold face.
Protein Protein Name Peptides
Gene
Symbol
Fold Change P Value
Pathway
WD30030 WD10784 WD30030 WD10784
Cre09.g396650.t1.2 Phosphate acetyltransferase 2 PAT2 3.49 8.67 0.0172 0.0025 Acetate utilization
and formation
Cre06.g268750.t1.2 NAD malic enzyme 10 NAD-
ME2
3.74 4.31 0.0019 0.0013 Tricarboxylic acid
cycle
Cre10.g423250.t1.2 Malate dehydrogenase 12 MDH2 2.53 2.25 0.0095 0.0151
Cre12.g514750.t1.2 Citrate synthase 14 CIS1 1.54 2.16 0.0439 0.0068
Cre05.g241850.t1.2 ATP citrate lyase, subunit A 3 ACLA1 8.67 3.42 0.0029 0.0211
Cre02.g088600.t1.2 ATP citrate lyase, subunit B 11 ACLA2 2.29 2.34 0.0444 0.0414
Cre12.g526800.t1.2 6-Phosphogluconate
dehydrogenase




12 GAP1a 10.18 14.15 0.0018 0.0011
Cre12.g553250.t1.2 Phosphofructokinase 3 PFK2 3.06 3.71 0.0285 0.0173
Cre17.g721500.t1.2 Starch synthase,
chloroplastic




19 PHOA 1.86 2.86 0.033 0.005
Cre12.g552200.t1.2 Glycogen/starch/alpha-
glucan phosphorylase
6 PHOB 1.40 1.82 0.173 0.044
Cre06.g278210.t1.1 Phosphoglucomutase 22 GPM1 2.41 2.61 0.0043 0.0032
Cre13.g566650.t2.1 Putative long-chain acyl-CoA
synthetase
10 LCS2 3.10 2.59 0.0036 0.0068 FA and lipid
metabolism
Cre16.g687350.t1.2 Acyl-CoA oxidase 4 ACX3 2.51 4.18 0.0327 0.0076
Cre17.g723650.t1.2 Acetyl-CoA Acyltransferase 20 ATO1 5.31 2.29 0.0072 0.0657
Cre01.g053000.t1.2 Glycerol-3-P dehydrogenase 12 GDPH 2.03 3.67 0.0520 0.0072
Cre01.g000300.t1.1 1-acylglycerol-3-P
O-acyltransferase
6 GDP8 2.94 6.69 0.0177 0.0024
Cre09.g405500.t1.1 Major LD protein 3 MLDP1 3.16 1.99 0.022 0.046




15 ECH1 1.79 0.99 0.039 0.957
NP_958385.1 PSII reaction center protein
H (PSII-H)
4 PsbH 1.51 0.99 0.0018 0.8800 Photosynthesis
Cre12.g508750.t1.2 Chl a/b binding protein
domain
2 Lhca2 4.14 1.04 0.02 0.93
Cre06.g284200.t1.2 Chl a/b binding protein,
chloroplastic
7 Lhcbm9 0.92 3.90 0.7670 0.0067
Cre13.g568800.t1.2 NADH-ubiquinone
oxidoreductase




2 NDA1 1.28 7.32 0.7203 0.0371
Cre10.g458450.t1.1 Glutathione peroxidase 15 GPXH 2.05 3.00 0.0321 0.0080 Redox homeostasis
Cre09.g391900.t1.1 Thioredoxin h1 15 TRXH 5.53 4.39 0.0008 0.0013
Cre16.g688550.t1.2 Glutathione-S-transferase 18 GSTS1 9.68 17.29 0.0004 0.0002
Cre03.g145787.t1.1 HSP 22C 8 HSP22C 1.38 10.38 0.3935 0.0021 Heat shock proteins
Cre16.g677000.t1.2 HSP 70E 23 HSP70E 2.08 3.29 0.0034 0.0006
Cre06.g250100.t1.2 HSP 70B 38 HSP70B 1.54 2.25 0.0107 0.0011
Cre01.g029650.t1.1 Subunit of retromer complex 5 VPS35 3.60 4.66 0.0018 0.0009 Endocytosis
Cre17.g728150.t1.2 R-SNARE protein, YKT6-
family
3 YKT6 13.87 12.18 0.0046 0.0055 SNARE interactions in
vesicular transport
Cre06.g269950.t1.2 Flagellar-associated protein 22 CDC48 2.16 3.16 0.0342 0.0092 Protein processing in
ER
Cre06.g278163.t1.1 Acetyl-Orn aminotransferase 2 ARG9 1.45 7.69 0.3754 0.0054 Biosynthesis of amino
acidsCre06.g252650.t1.2 Isopropylmalate
dehydratase, small subunit
2 LEU1S 2.23 3.42 0.0245 0.0056
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To evaluate the reliability of the RNA-Seq results, we
performed reverse transcription quantitative PCR (RT-
qPCR) on 12 genes (acetyl-CoA synthetase [ACS1], Per-
oxisomal acyl-coenzymeAoxidase 1 [ACX1], acetyl-COA
biotin carboxyl carrier protein1 [BCC1], citrate syn-
thase [CIS1], diacylglycerol acyltransferase, DAGAT
Type 2 [DGTT1], 3-ketoacyl-ACP-synthase [KAS2],
lecithin:cholesterol acyltransferase [LCA1], mitochon-
drial pyruvate dehydrogenase complex, E1 component,
alpha subunit [PDC1], phosphofructokinase [PFK1],
glycerol-3-phosphate acyltransferase [PLSB1], pyru-
vate Kinase [PYK1], and ADP-glucose pyrophosphor-
ylase small subunit [STA6]) using RNA from cells
prepared using the same treatment conditions used for
RNA-Seq (Supplemental Dataset S3; Supplemental Fig.
S4). These genes were selected to represent a range of
targets identified to be important for lipid accumula-
tion in Chlamydomonas. For all 12 genes, the expression
patterns from RNA-Seq and RT-qPCR were compara-
ble as demonstrated by correlation coefficients near 1.0
(WD10784 R2 5 0.96; WD30030 R2 5 0.9).
To further understand the metabolic outcomes of
pathway changes identified through proteomic and
transcriptomic analyses, an untargeted high-resolution
metabolomics approach was employed to assess levels
of low-molecular–weight polar metabolites. The dif-
ferentially abundant features in each treatment group
were compared with the untreated controls, features
with intensity ,1,000 were filtered out, and then sta-
tistical analysis was performed on the remaining fea-
tures in the set. Differentially abundant features were
defined as those having a log2FC change in abundance
$ 2 or # 22 with P values # 0.01. A total of 11,752
aligned features were identified, of which 939 (8%) and
1,124 (9.56%) features were significantly changed by
compound WD30030 and WD10784 treatments, re-
spectively (Supplemental Dataset S4; Supplemental
Fig. S5). Of these, 371 were unique toWD30030, 556 to
WD10784, and 568 were common to both compound
treatments.
To ascribe metabolite identifications to the features
whose abundance was significantly different between
treatments, Mummichog (http://mummichog.org/)
analysis was performed using theMetaboanalyst server
(http://www.metaboanalyst.ca/) using mass accura-
cies of 0.1 ppm and a P value cutoff of 0.0001. Masses
were searched in “positive ionization” mode using the
Arabidopsis metabolic model as background. This
Table 2. Selected proteins with decreased abundance after compound treatment (from Supplemental Datasets S1 and S5–S13).
Significant fold change and P values are indicated in bold face.
Protein Protein Name Peptides
Gene
Symbol
Fold Change P Value
Pathway
WD30030 WD10784 WD30030 WD10784
Cre03.g158900.t1.2 Dihydrolipoamide acetyltransferase 21 DLA2 0.41 0.36 0.0137 0.0084 Carbon
metabolismCre01.g010900.t1.2 Glyceraldehyde-3-P dehydrogenase 26 GAP3 1.08 0.23 0.7135 0.0018
Cre02.g141400.t1.2 Phosphoenolpyruvate
carboxykinase 1
— PCK1 0.84 0.49 0.5162 0.0430
Cre12.g511900.t1.2 Ribulose-P 3-epimerase 4 RPE1 0.24 0.19 0.0025 0.0014
Cre03.g185550.t1.2 Sedoheptulose-1,7-bisphosphatase 14 SEBP1 0.58 0.29 0.0598 0.0041
Cre14.g630847.t1.1 Transaldolase 11 TAL2 0.55 0.23 0.0844 0.0048
Cre02.g080200.t1.2 Transketolase 19 TRK1 0.58 0.25 0.0487 0.0020
Cre06.g282800.t1.2 Isocitrate lyase 22 ICL1 0.72 0.15 0.0472 0.0002 Glyoxylate
cycleCre03.g144807.t1.1 Malate synthase — MAS1 1.02 0.44 0.9388 0.0249
Cre13.g567950.t1.2 Glc-1-P adenylyltransferase 17 STA1 0.65 0.44 0.104 0.016 Starch
metabolismCre03.g188250.t1.2 Glc-1-P adenylyltransferase 3 STA6 0.72 0.36 0.203 0.003
Cre08.g359350.t1.2 Biotin carboxylase, acetyl-CoA
carboxylase component
7 BCR1 0.72 0.36 0.287 0.020 FAs and lipids
Cre06.g284250.t1.2 Chl a/b binding protein,
chloroplastic
14 LHCBM8 0.07 0.57 0.0047 0.3003
Cre02.g077300.t1.2 Nucleolar protein 6 NOP1 0.27 0.13 0.0063 0.0011 Ribosomes
Cre06.g264350.t1.2 Plastid ribosomal protein L13 6 PRPL13 0.19 0.12 0.0035 0.0013
Cre06.g299000.t1.2 Plastid ribosomal protein L21 2 PRPL21 0.25 0.09 0.0097 0.0013
Cre06.g272850.t1.2 Plastid ribosomal protein L10 2 PRPL10 0.45 0.26 0.0480 0.0086
Cre02.g091100.t1.2 Ribosomal protein L15 2 RPL15 0.70 0.20 0.2988 0.0059
Cre02.g102250.t1.2 Ribosomal protein S3 6 RPS3 0.35 0.35 0.0053 0.0051
Cre06.g272800.t1.2 40S ribosomal protein S8 16 RPS8 0.54 0.52 0.0032 0.0024
Cre06.g259850.t1.2 Mitochondrial ribosomal protein
L29
2 MRPL29 0.12 0.05 0.0021 0.0005
Cre17.g734450.t1.2 Plastid ribosomal protein L19 3 PRPL19 1.13 0.52 0.4259 0.0077
Cre13.g581650.t1.2 Plastid ribosomal protein L7/L12 18 PRPL7/
L12
0.46 0.37 0.0216 0.0093
Cre16.g659950.t1.1 Plastid ribosomal protein S5 7 PRPS5 0.47 0.33 0.0041 0.0010
Cre02.g083950.t1.1 Plastid-specific ribosomal protein 3 6 PSRP-3 0.57 0.44 0.0170 0.0047
Cre01.g039250.tl. Cytosolic 80S ribosomal protein S2 17 RPS2 0.60 0.36 0.0828 0.0099
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analysis identified 134 unique metabolites significantly
increased after WD30030 treatment, whereas 125 were
increased after WD10784; 257 metabolites were shared
between the two. Similarly, 26 metabolites were de-
creased in abundance by WD30030 alone, 75 decreased
by WD10784, and 204 were shared between the two
treatments (Supplemental Fig. S5).
Effect of Compound Treatments on Acetate Utilization,
acetyl-CoA Generation, and Central Carbon Metabolism
In this study, Chlamydomonas was grown mixotroph-
ically on acetate as a source of carbon. Acetate assimi-
lation occurs by two pathways: It is either directly
converted to acetyl-CoA upon import in a reaction cat-
alyzed by ACS1, ACS2, or ACS3, or it is metabolized to
acetyl-CoA via a two-step reaction catalyzed by acetate
kinase (ACK1 or ACK2) and P acetyltransferase (PAT1
or PAT2). Alternatively, a recent study proposed a po-
tential acetate permease GFY 3-5 may be involved in
acetate uptake (Goodenough et al., 2014). Only three
proteins were detected in proteomics experiments and
among these, neither ACS3 nor ACK2 protein levels
were significantly affected by compound treatments
(Supplemental Dataset S5), whereas PAT2 was in-
creased by both. Based on RNA-Seq data, transcript
levels of ACK1, ACK2, and PAT1 were significantly
higher than controls after treatment with either com-
pound. These data suggest that the two-step pathway
to acetyl-CoA is induced to potentiate acetate assimi-
lation under compound treatment. Similar results were
observed during nitrogen starvation (Wase et al., 2014;
Park et al., 2015).
Once formed, acetyl-CoA may be oxidized in the
tricarboxylic acid cycle to produce NADH, FADH2,
ATP, and CO2 (Johnson and Alric, 2013). NADH and
FADH2 are further oxidized by the electron transport
chain to yield ATP through oxidative phosphorylation
(OxPhos). At the protein level, the abundance of six of
14 tricarboxylic acid cycle–associated proteins identi-
fied and quantified were significantly increased by ei-
ther WD30030 or WD10784 (Table 1; Supplemental
Dataset S5). Transcripts encoding both glyoxylate cycle
enzymes, isocitrate lyase and malate synthase, were
reduced by either compound treatment although, for
protein abundance, only WD10784 treatment resulted
in reduced enzyme levels (Table 2). The reduction in
abundance of the glyoxylate cycle enzymes is in con-
trast to results obtained after nitrogen starvation of
starchless strains where both were increased (Blaby
et al., 2013).
Among the most significant alterations in enzymes
that lead to FA and lipid synthesis were increases in the
abundance of citrate synthase (both CIS1 and CIS2),
malic enzyme (NAD_ME2), and ATP citrate lyases
(ACL1 and ACL2; Table 1; Supplemental Dataset S5).
These critical enzymes promote the production of cy-
tosolic acetyl-CoA to provide substrates and reducing
power to FA synthesis. Previously, citrate levels were
determined to be unchanged by WD10784 treatment,
but were increased significantly by WD30030 (Wase
et al., 2017).
Gluconeogenesis and the Calvin–Benson–Bassham
cycle pathways are responsible for generating 6-C
backbones that provide substrates to the oxidative pen-
tose P pathway and monosaccharide synthesis. It has
been reported that the 6-C backbones can also be ca-
tabolized via glycolysis leading to acetyl-CoA produc-
tion for FA synthesis (Johnson and Alric, 2013). There
was no effect on protein levels of Rubisco, the rate-
limiting enzyme of the Calvin–Benson–Bassham cy-
cle after either compound treatment. However, RNA
levels were reduced, particularly by WD10784, sug-
gesting a future impact as the protein turns over.
It was noted that the transcript and protein expres-
sion of additional key enzymes in these interrelated
pathways including 6-phosphofructokinase (PFK2),
glyceraldehyde-3-P dehydrogenase (GAP1), and 6-
phosphogluconate dehydrogenase (6PGD) were sig-
nificantly increased by both treatment conditions
(Table 1; Supplemental Dataset S2). Protein levels of
pyruvate kinase (PYK2) were unchanged.
Fru-1,6 bisphosphate aldolase (FBA) generally func-
tions in both gluconeogenesis and the Calvin–Benson–
Bassham cycle and catalyzes the synthesis of 6-C
Fru-bisphosphate from two 3-C sugars, dihydroxyace-
tone P, and glyceraldehyde-3-P (G3P). None of the
FBA proteins were identified in label-free proteomics
analyses, but at the transcript level, three genes en-
coding FBA were reduced, whereas FBA4 transcript
abundance was significantly increased by both treat-
ment conditions. The next enzyme in the pathway, Fru-
1,6-bisphosphatase (FBP1), had reduced transcript
abundance but was increased at the protein level;2-fold
after either compound treatment. Metabolite analysis
indicated reduction in Fru-1,6-bisphosphate and ele-
vation of Fru-6-P (17-fold by WD30030 and 300-fold
by WD10784). This subsequently resulted in elevation
of Glc-6-P and Glc-1-P levels, substrates for starch
synthesis.
An additional 12 proteins of enzymes in the Calvin–
Benson–Bassham cycle were identified and compared
(Supplemental Dataset S5). Of these, only the abundance
of one, Ribulose-P 3-epimerase (RPE1), was reduced by
both compounds; all others were not significantly
different from controls. WD10784 treatment also re-
duced glyceraldehyde/erythrose P dehydrogenase
family, transketolase (TRK1), RPE1, and sedoheptulose-
1,7-bisphosphatase (SEBP1). This marks a key difference
in the metabolic response to WD30030 compared with
WD10784, demonstrating the latter compound could
eventually reduce the function of the Calvin–Benson–
Bassham cycle and production of hexose products from
carbon dioxide. When metabolites were examined, ery-
throse 4-P was increased after either treatment, whereas
ribose 5-P and D-xylulose 5-P were found to be signifi-
cantly increased only after WD10784 treatment. The
6-phosphogluconate, an intermediate in the pentose
phosphate and Entner–Doudoroff glycolytic pathway,
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was significantly increased by either treatment (Fig. 3;
Supplemental Dataset S4).
An important consideration for glycerolipid synthe-
sis is the transport of glycerol-3-P from the chloroplast
to the cytosol to fuel lipid synthesis in the ER. Two
predicted triose phosphate transporters and four
nucleotide-sugar transport members were identified in
RNA-Seq experiments (Supplemental Dataset S5). All
were elevated by both compound treatments. Among
these one, Cre16.g663800.t1.2, is predicted to localize to
the chloroplast. It was increased 6- to 7-fold by either
WD30030 or WD10784.
Starch Metabolism
Wase et al. (2017) previously reported that WD10784
increases starch accumulation whereas WD30030 does
not, therefore we sought to understand this diversifi-
cation of storage outcomes using the multiomics data.
Metabolite analysis demonstrated that levels of sub-
strates for early steps in starch synthesis were highly
elevated after either compound treatment including
Fru-6-P, Glc-6-P, and Glc-1-P (Fig. 4; Supplemental
Dataset S4; Wase et al., 2017). Glc-1-P adenylyl-
transferase catalyzes the rate-limiting step in the starch
synthesis pathway, which controls the flux of carbon
into starch. The regulatory architecture is composed of
the large regulatory STA1 enzyme (Cre13.g567950.t1.2)
and small catalytic STA6 enzyme (Cre03.g188250.t1.2).
In nitrogen starvation, starch levels were increased co-
incident with a reduction in both the STA1 and STA6
enzyme levels (Miller et al., 2010; Msanne et al., 2012;
Schmollinger et al., 2014; Wase et al., 2014). WD10784
treatment resulted in a significant reduction in STA1
and STA6 proteins, but an increase in STA2 protein;
protein levels were not significantly different from
controls after treatment with WD30030 (Tables 1 and
2; Fig. 4; Supplemental Dataset S5). Expression of a
number of genes of starch biosynthesis were increased
only in cells treated with WD10784. These included,
for example, phosphoglycerate mutase1 (PGM5) and
glycogen/starch/a-glucan phosphorylase (PhoA and
PhoB). The abundance of several other enzymes was
increased by both compound treatments, although
impact of WD10784 was more substantial in each case,
resulting in high levels of RNA encoding GAP1, ATP-
dependent PFK2, starch branching enzyme (SBE1),
FBA4, and UTP-Glc-1-P uridylyltransferase (UGP1).
Also significantly increased by treatment with either
compound were two transcripts that were identified
as encoding a-amylase, an enzyme required for starch
breakdown. The balance between starch synthesis
and breakdown has been invoked as important for the
Figure 3. Boxplot illustration of differential expression of selected metabolites. One-way ANOVA was performed for multiple
group comparison. Adjusted P value was calculated using Bonferroni–Hochberg (n 5 3 biological replicates).
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potentiation of lipid synthesis in nitrogen deprivation
whereby inhibition of starch synthesis results in lipid
accumulation (Li et al., 2010).
Lipid Metabolism
A primary goal of this workwas to identify factors and
mechanisms that impact lipid synthesis and storage in
response to the small molecule activators. The increase
in lipid accumulation could be due to induction of lipid
synthesis and storage pathways, decrease in degradation
pathway components, or increased substrate availabil-
ity and utilization. Notably, a prior strong case has been
made for increased citrate levels leading to FA biosyn-
thesis and ultimately storage in complex lipids, particu-
larly TAGs (Wase et al., 2014, 2017). As mentioned above
in the "Effect of Compound Treatments on Acetate
Utilization, acetyl-CoA Generation, and Central Car-
bon Metabolism" section, this is supported in part by
increased levels of CIS and ACL at both the protein
and RNA levels after treatment with either compound.
Activity of the FA biosynthetic pathway might be
expected to increase to provide FA substrates for TAG
synthesis in response to the lipid-inducing com-
pounds. Acyl-carrier protein1 (ACP1) was not detec-
ted in the proteomics analysis and ACP1 transcripts
were not affected by either treatment. ACP2 protein
abundance was unchanged whereas transcript abun-
dance was significantly decreased by both compounds
(Supplemental Dataset S6). Acetyl-CoA biotin carboxyl
carrier protein2 (BCC2)was increased 5.6- and 15.8-fold
by WD30030 and WD10784 treatments, respectively,
but the corresponding transcripts were decreased in
abundance (Table 1; Supplemental Dataset S6). There
was no evidence that other FA biosynthetic enzymes
Figure 4. Changes in transcript (squares)
and protein (circles) levels for enzymes in
the starch biosynthesis and degradation
pathways after treatment with lipid-
inducing compounds. Dashed arrows
indicate multiple enzymatic steps. Fold
change values of metabolite levels are
given as numbers (see also Supplemental
Datasets S1, S2, and S5). Enzyme abbre-
vations: SBE1, starch branching enzyme;
SSS5, soluble starch synthase; STA1 and
6, glucose-1-phosphate adenylyltransfer-
ase; AMA2, 3, amylase DPE:dispro-
portionating enzyme;HXK1, hexokinase;
PGM2, 5, phosphoglucomutase; PFK1,
phosphofructokinase; FBP1, fructose
1,6-bisphosphatase; FBA, fructose-
bisphosphate aldolase; PCK1, phos-
phoenolpyruvate carboxykinase; PHOA,
B, a-1,4 glucan phosphorylase
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were increased in abundance by either compound.
Notably increased at the RNA level were two long-
chain acyl-CoA synthetases LCS1 and LCS3. These
proteins are required for complex lipid synthesis be-
cause acyl-CoAs are the activated substrate for the
synthetic pathways. Among components of the FA
desaturase family, no proteinswere detected. However,
RNA levels were substantially increased for fatty acid
desaturase2.a (FAD2.a) and FAD5c, whereas fatty acid
desaturase3 (FAD3), monogalactosyldiacylglycerol syn-
thase Galvestine-1-specific palmitate delta-7 desaturase
(FAD5a), and chloroplast glycerolipid omega-3 fatty
acid desaturase (FAD7) were significantly decreased.
Several enzymes and proteins required for TAG
synthesis and storage were induced at the transcript
level (Supplemental Dataset S6; Fig. 5). These included
the diacylglycerol acyltransferases (DGATs) DGTT1,
DGTT3, and DGTT5, as well as three other acyltrans-
ferases. Among these was PDAT1, encoding phos-
pholipid:DGAT, whose expression was increased in
response to WD30030, whereas it remained at base-
line after WD10784 treatment. There were increases
in transcripts encoding three enzymes involved in
sulphoquinovosyl diacylglycerols, which are essen-
tial for structure and function of thylakoid mem-
branes. Additionally, transcripts for LD-associated
proteins including major lipid droplet protein (MLDP),
CDP-ethanolamine:DAG ethanolamine phosphotransfer-
ase, and putative lysophosphatidylcholine acyltransferase,
were all elevated compared with controls in response to
either compound. Of these, only MLDP1 protein was
identified in the proteomics experiment and it was found
to be induced by both compounds (Table 1). These data
follow a trend seen for other lipid-inducing conditions,
including nitrogen starvation, in which the abundance
of FA biosynthetic enzymes were either unchanged or
decreased, while complex lipid synthetic enzymes were
induced (Miller et al., 2010; Alboresi et al., 2016).
Several TAG lipases that degrade storage lipids had
lower abundance in compound treatment conditions,
which may have also contributed to TAG accumulation.
These included LIP1 and two other lipases encoded
by transcripts Cre17.g698600.t1.1 and Cre07.g334150.t1.1.
The transcripts of each were greatly reduced under
either treatment condition whereas other lipases in-
cluding phospholipase A2 (Cre08.g381250.t1.2) and
ELT3 (Cre03.g146287.t1.1) were induced by both the
treatments.
Amino Acid and Nitrogen Metabolism
A notable impact of treatment with the selected lipid-
inducing compounds profiled by our group previously
Figure 5. Changes in transcript (squares) and protein (circles) abundance relative to controls for enzymes in the TAG biosynthesis
and degradation pathways after treatment with lipid-inducing compounds (see also Supplemental Datasets S1, S2, and S6).
AGPAT, 1-acylglycerol-3-phosphate-O-acyltransferase; DAG, diacylglycerol; PLSB,Glycerol-3-phosphate acyltransferase, chlo-
roplastic; LCS, long chain acyl-CoA synthetase; MAG, Monoacylglycerol; PDAT, phospholipid:diacylglycerol acyltransferase.
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and herein by untargeted metabolomics was an in-
crease in the abundance of intermediates and products
of amino acid biosynthetic pathways (Wase et al., 2017;
Supplemental Data S4). Arg was significantly increased
by both compounds. L-His accumulated 8-fold with
compound WD30030 and 4-fold with WD10784 treat-
ments. Levels of aliphatic amino acids L-Leu and L-Val
were both significantly increased as a result of com-
pound treatments. Of the two sulfur-containing amino
acids, L-cystine and L-Met, only Met levels were sig-
nificantly increased. Of the aromatic amino acids, L-Tyr,
L-Phe, and L-Trp levels were significantly elevated by
both compounds. By contrast, nitrogen starvation re-
sults in a reduction in Glu, Gln, Asp, Put, Gly, and Ala
(Wase et al., 2014; Park et al., 2015).
Nineteen proteins categorized into amino acid me-
tabolism pathways were identified in these analyses; of
these, six were significantly different in response to ei-
ther compound treatment and three byWD10784 alone
(Supplemental Dataset S7). Among these proteins, iso-
propyl malate isomerase (LEU1L; Cre01.g004500.t1.2),
required for Leu biosynthesis, was increased in abun-
dance by 3-fold in response to WD10784 treatment.
Recently, it was suggested that Leu may be involved in
the regulation of lipid metabolism in Yarrowia lipolytica
because supplementation of culture medium with Leu
resulted in higher lipid accumulation (Blazeck et al.,
2014). It was hypothesized that elevated Leu levels re-
press amino acid biosynthesis and redirect carbon flux
toward lipid metabolism (Kerkhoven et al., 2016). Our
observations do not support this hypothesis, as amino
acid biosynthesis was largely potentiated by the lipid-
inducing compound treatments and there was no evi-
dence that carbon surplus from amino acid and protein
degradation served as a source of substrates for lipid
synthesis and storage.
For the KEGG pathway termed “nitrogen metabo-
lism,” only five proteins were identified while 62 tran-
scripts were identified (Supplemental Dataset S7).
Among the transcripts, 56were differentially abundant.
Among the proteins, Glu dehydrogenase and Glu
synthetase were increased ;2-fold by WD30030 treat-
ment at the protein level, but there was no effect elicited
by WD10784 treatment. Overall, WD10784 increased
the abundance of most transcripts identified. WD30030
treatment decreased the abundance of the transcripts
for several transporters, including the ammonium trans-
porter AMT5, sodium transporter DUR5, and formate/
nitrate transporter NAR1-2. In nitrogen starvation, there
is a notable induction of transcripts and proteins involved
in ammonia assimilation including periplasmic L-amino
acid oxidase (LAO), ammonia transporters, and enzymes
of the glutamine synthetase and glutamate synthase (GS/
GOGAT) system (Schmollinger et al., 2014; Wase et al.,
2014; Kerkhoven et al., 2016). In contrast, neither lipid-
inducing compound treatment altered LAO1, LAO2, or
LAO3 transcript levels, whereas NRT2.1 and NRT2.4
were repressed, and NRT2.5 was increased, especially
in response to WD10784. Transcripts encoding enzymes
of the GS/GOGAT system that are normally induced
during nitrogen starvation were repressed by either
compound treatment. These results are in direct oppo-
sition to those reported in nitrogen deprivation and
further emphasize the unique opportunity to modify
metabolism to enhance lipid production without star-
vation (Miller et al., 2010; Schmollinger et al., 2014;
Wase et al., 2014).
Differential Impacts of the Compounds on Protein and
RNA Levels for Components of Photosynthesis
and Photorespiration
During nitrogen limitation, which is frequently used
to induce lipid synthesis and storage, chlorosis of the
culture is observed primarily due to downregulation of
PSI and PSII proteins, the light-harvesting complexes
(LHCs) cytochrome b6f and ATP synthase (Lee et al.,
2012; Schmollinger et al., 2014; Wase et al., 2014; Park
et al., 2015). Previously, it was reported that WD30030
treatment did not cause chlorosis and there was no re-
duction in Chl a or b, nor was there a reduction in total
carotenoids (Wase et al., 2017). By comparison, there
was a 50% reduction in pigment levels when cells were
treated with WD10784 after 72 h, which led to concerns
that photosynthesis would be reduced over time with
this compound. These findings were extended to dem-
onstrate that the maximal photosynthetic rates were
similar between control and cells treated with either
compound up to 72 h (Fig. 6A). The relative quantum
yield per milligram of CHL (i.e. the initial slope of the
light saturation curves) did not vary markedly between
the different treatment conditions. Similarly, the respi-
ratory rates of control and compound-treated cells were
not statistically different up to 48 h, after which they
started to decline (Fig. 6B). These data substantiate the
modest impact of the compound treatments on growth
and cellular function.
Assessment of both gene and protein expression
profiles provided further insight into the impact of the
compounds on the photosynthetic proteins and genes.
In previous studies, proteins of PSI and PSII were found
to be significantly reduced during nitrogen starvation
(Longworth et al., 2012; Wase et al., 2014). In contrast,
protein levels were relatively stable duringWD30030 or
WD10784 treatments; only PSI reaction center subunit
IX (NP_958417.1) was significantly reduced by both the
treatment conditions at 72 h (Supplemental Dataset S8).
A differential response was observed after compound
treatment for the subunits of the LHCs. LHCA2 was
increased 4-fold by WD30030 (P , 0.05), whereas the
abundance of this proteinwas not affected byWD10784
(Table 1). Several LHC proteins such as LHCA4,
LHCBM2, LHCBM3, LHCBM5, and LHCM6 were
decreased after WD30030 treatment, but remained
unchanged by WD10784. The subunits of the oxygen-
evolving complex that are generally reduced dur-
ing nitrogen starvation retained their abundance
(Supplemental Dataset S8). Although not identified
in RNA-Seq experiments, 16 proteins encoded by the
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plastid genome were identified by label-free proteo-
mics (Supplemental Dataset S8). Thirteen remained
unaffected by either compound treatment. PsbH in-
creased in response to WD30030; PetB encoding
Cytochrome b6f was reduced ;50% by WD10784;
and both compounds had reduced PSI reaction center
subunit IX.
To verify the impact of the compound treatments
on proteins involved in photosynthesis, western blot
analysis was performed on six selected proteins (Fig. 7).
WD30030 treatment did not affect protein abundance of
the large and small subunits of Rubisco, PFL, phos-
phoribulose kinase (PRK), PsbA, or histone, which was
included as a loading control. In contrast, WD10784
decreased the abundance of PRK. These results verify
findings from untargeted, global proteomic assessment
that showed only WD10784 had a significantly adverse
effect on the photosynthetic machinery. WD30030 had
no impact on proteins linked to the antenna proteins
and photosynthesis, whereas WD10784 reduced the
abundance of proteins in both categories. Reduction in
the antenna apparatus has been suggested as one way
to limit excess excitation energy and increase algal bi-
omass (Nama et al., 2015; de Mooij et al., 2016;
Girolomoni et al., 2017).
At the transcript level, most genes encoding pro-
teins of Rubisco, PSI, PSII, and the LHCs were sig-
nificantly reduced by both compounds and, in keeping
with the more severe impact on growth, treatment
with WD10784 was more repressive than WD30030
(Supplemental Dataset S8). Therefore, it is presumed
that, over time (i.e. beyond 72 h), compound treatment
would reduce the levels of these proteins, most likely
eventually leading to a reduction in photosynthetic
capacity. Importantly, these results point to significant
differences in the metabolic status of the algal cells be-
tween nutrient deprivation conditions compared with
treatment with our lipid-inducing compounds, which
supports both growth and lipid accumulation.
Protein Abundance of OxPhos and Respiratory Pathway
Components Are Largely Unaltered by
Compound Treatment
In previous proteomics analyses of nitrogen-starved
cells, many proteins and enzymes of oxidative phos-
phorylation were significantly increased in abundance,
suggesting protein expression was induced to com-
pensate for energy deficiencies (Wase et al., 2014). In
this study, among a large number of proteins (41) in-
volved in OxPhos and respiration identified and quan-
tified, only three proteins were significantly altered by
WD10784 treatment and nonewere altered byWD30030
treatment (Supplemental Dataset S9). Of the four, in
complex I, one protein (NUOB12) was significantly
increased (P , 0.05) by WD10784 at both the protein
and transcript levels. In complex II, SDH2 succinate
Figure 6. Photosynthetic and respiratory rates during compound treatments. A, Photosynthetic rates of compound-treated cells
measured at 24-h intervals for 72 h using a Clark oxygen electrode. Rates are expressed as O2 evolved per milligram of Chl (n5 3
biological replicates;6SD). B, Respiratory rates were similarly determined bymeasuring oxygen consumption. Twoway-ANOVA
with Bonferroni posttest was applied to determine changes in experimental group over time (n5 36 SD). Statistically significant
differences are indicated by *P # 0.05, **P # 0.01.
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dehydrogenase [ubiquinone] iron–sulfur subunit
(Cre06.g264200.t1.2) was significantly reduced in abun-
dance. In addition to the proton pumping complex I,
Chlamydomonas contains several type-II NAD(P)H de-
hydrogenases. These enzymes are located on the mito-
chondrial inner membrane surface and facilitate electron
transport from NAD(P)H to ubiquinone. Two proteins
were profiled, of which only one (Cre16.g691552.t1.1;
NDA1) was increased 7-fold by compound WD10784
treatment.
RNA-Seq data reflected the minimal impact on the
expression of genes encoding proteins involved in these
pathways (Supplemental Dataset S9). The abundance
of very few transcripts was significantly different for
proteins encoding complex I proteins. For other OxPhos
complexes, a number of transcripts were increased in
abundance, particularly after treatment withWD10784.
This is more similar to the changes in transcript abun-
dance after nitrogen deprivation (Miller et al., 2010).
Transcript analysis showed that some components of
complex IV were increased including COX16, COX17,
and mitochondrion-associated cytochrome c oxidase
assembly factor, especially after WD10784 treatment.
Five proteins in this complex were identified, but none
were significantly different from controls.
Evaluation of Cellular Redox Status
Reactive oxygen species (ROS), which are by-
products of aerobic metabolism, may act as signal-
ing molecules or indicators of stress in various algal,
plant, and animal systems (Szivák et al., 2009; Menon
et al., 2013). GSH is an efficient scavenger of ROS,
and levels of reduced GSH rise in response to various
culture and stress conditions to compensate for ele-
vated ROS. CompoundWD10784 increased both ROS
and GSH levels significantly (2- and 4-fold, respec-
tively), whereas WD30030 increased only GSH
(2-fold; Fig. 8). Cells mitigate increased oxidative
stress by inducing the expression of scavenging enzymes
such as superoxide dismutase, catalase, and glutathi-
one reductase (GR). Proteomics and transcriptomics
analyses identified 22 proteins and 34 transcripts in the
redox homeostasis pathways after treatment with ei-
ther compound (Supplemental Dataset S10). Overall,
these data further reflect the stronger increase in redox
stress response by treatment with WD10784 as com-
pared with WD30030. However, both compounds in-
duced a manganese superoxide dismutase (MSD1),
encoded by Cre02.g096150.t1.2 (increased 2- to 2.5-
fold by both compounds at the protein level and 3-fold
at the RNA level). Likewise, a glutathione reductase
(GSHR2; Cre09.g396252.t1.1) was increased 4- and
11-fold, respectively, for WD30030 and WD10784 at
the protein level. However, this enzyme was only
modestly increased at the RNA level (2-fold each).
Catalase (CAT1; Cre09.g417150.t1.2) protein levels
were not affected by either compound, and RNA levels
were modestly reduced.
Impacts on Ribosomal Protein Components
Reduced expression of ribosomes under stress con-
ditions including nitrogen starvation was first reported
in early work using ultrastructure studies (Martin et al.,
1976). This was more recently confirmed using quan-
titative proteomics and transcriptomics (Martin et al.,
1976; Schmollinger et al., 2014; Wase et al., 2014). In
this study, 84 cytoplasmic, plastidic, and mitochon-
drial ribosomal proteins were identified and quantified
(Table 2; Supplemental Dataset S11). Few cytosolic ri-
bosomal proteins were significantly downregulated
in the cells treated with either compound. Of these,
the average reduction was 35% to 40% with WD30030
and 55% to 60% for WD10784 as compared with un-
treated control cells. Interestingly, ribosomal protein
L29 (Cre03.g207050.t1.2; RPL29) was significantly in-
creased in cells treated with compound WD10784. This
protein is suggested to be necessary for the stable as-
sembly of the large subunit of chloroplast ribosome
(Myers et al., 1984).
Mitochondrial and plastidic ribosomal components
were more profoundly impacted by the compound treat-
ments (Supplemental Dataset S11). Most mitochondrial
Figure 7. Verification of the impact of compound
treatment on selected proteins identified in label-
free proteomic analysis using western blotting. A,
Data from label-free proteomic analysis expressed
as fold-change compared with control samples. B,
Expression of the selected proteins in cell extracts
was visualized using targeted antibodies. (Note:
All lanes are from a single gel, but column 3 was
two lanes distal from lane 2.)
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ribosomal protein transcripts were increased by either
compound treatment and, of two proteins identified, nei-
ther were significantly changed in abundance. Among the
17 plastidic ribosomal proteins identified and compared to
untreated controls, 10 were significantly reduced by
WD30030 treatment and 11 by WD10784 treatment. The
most severely affected were PRPL11, PRPL13, and
PRPL21 (70% to 85% reduced). Itwas noted thatWD10784
reduced plastidic ribosomal proteins and transcripts, in
most cases, more severely than WD30030, which further
supports the contention that this compound inducesmore
metabolic dysfunction than WD30030 at the same con-
centration and over the same culturing period.
Compound Treatment has Limited Impacts on Heat Shock
Response Factors and Chaperones
Chlamydomonas is generally grown at 25°C to opti-
mize growth rate. Elevated temperatures (35°C to 41°C)
result in the induction of heat shock proteins (HSPs)
and chaperonins that assist protein folding and as-
sembly (Kobayashi et al., 2014; Maikova et al., 2016).
Other stresses may induce the same proteins and sim-
ilar responses (Schroda et al., 1999; Schulz-Raffelt et al.,
2007; Maikova et al., 2016). The accumulation of heat
shock proteins (HSPs) correlates with heat shock factor
(HSF) hyperphosphorylation (Schulz-Raffelt et al.,
2007). Treatment of cells with either WD30030 or
WD10784 resulted in different impacts on HSP family
members (Supplemental Dataset S12). HSF1 was only
detected at the transcript level and was increased 1.7-
fold byWD10784 but was not affected byWD30030. Six
small HSFs of the HSP22 family were identified. Of
these, five were significantly increased in expression by
WD10784, whereas all were decreased by WD30030
treatment. The HSP60 family members are type I
chaperonins localized to plastid and mitochondria
(Bertsch et al., 1992). Of 19 transcripts and 11 proteins
identified, nonewere significantly altered byWD30030.
After WD10784 treatment, the transcripts of only three
GroEL-like proteins were induced and no proteins
levels were significantly increased. Similar results were
found for the HSP70s. These results indicate neither
compound significantly induced the heat shock stress
response.
Effects of Lipid-Accumulating Compounds on Factors
Involved in ER Stress, Autophagy, and Vesicle-Mediated
Lipid Transport
Recent evidence has indicated that LDs are synthe-
sized along an ER pathway involving vesicular traf-
ficking and are catabolized via autophagic processes
(Stordeur et al., 2014; Welte and Gould, 2017; Garcia
et al., 2018). Autophagy of LDs, sometimes called
“lipophagy,” plays an important role in lipid and pro-
tein homeostasis critical to energy control pathways.
Therefore, we examined these pathways to provide
insight into LD assembly and utilization after com-
pound treatment.
To test whether the lipid-accumulating compounds
induce ER stress in Chlamydomonas, we examined the
transcript and protein expression profile of selected ER
stress markers. For example, a previous study showed
that Brefeldin A, a compound that induces lipid accu-
mulation in algae, induces an ER stress response as
indicated by increased expression of classical ER stress
marker genes including Binding Protein1(BIP1) and
BIP2 and Sar-type small GTPase1 (SAR1; Kim et al.,
2013). WD10784 induced expression of BIP2 protein
2.3-fold but had no effect on Bip1 or SAR1. Twenty
transcripts were identified and categorized as part of
the autophagy pathway. Two, APG18 and APG20,
were induced by both compound treatments 2- to 3-
fold. Another, DIN1, was decreased 80% to 95% by
both. Among autophagy proteins, only DIN6 was
detected, and its abundance was not significantly al-
tered by either compound. Therefore, it does not appear
that either compound induces lipophagy.
The ARF1/COPI protein machinery, known for its
role in vesicle trafficking, is also implicated in the syn-
thesis, maintenance, and catabolism of LDs through a
mechanism that is poorly understood (Beller et al.,
2010). Only one protein was identified as a compo-
nent of this pathway, VPS26, but its abundance was not
affected by either treatment. Twenty-three transcripts
were identified that were categorized to the ARF/
COPII system (Supplemental Dataset S13). While both
compounds induced many of these transcripts, the
strongest induction was by WD10784 treatment.
Transcripts increased in abundance included ADP-
ribosylation factor (ARF family), ARF-like small GTPase
Figure 8. Evaluation of redox stress after com-
pound treatment. A, Levels of ROS estimated us-
ing an R-Glo H2O2 Assay Kit (Promega). B, Levels
of reduced GSH assessed using the GSH-Glo As-
say. Bar heights indicate the mean of three bio-
logical replicates, and error bars indicate the SD.
Significance was determined by Student’s t test
comparing the compound-treated samples with
control samples within the same experiment.
Statistical significance is indicated by NS, no
significance; *P # 0.05; **P# 0.01; ***P# 0.001.
RLU, relative luminescence unit.
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(ARL1), coatomer subunits (COPII a, b, g, and «),
vacuolar sorting proteins of the VPS family, SEC31,
two syntaxins, and a Septin 9 homolog. The increase
in components of this pathway is consistent with a
physiological state induced by the compounds that
favor complex lipid and protein synthesis involving
the ER and secretory apparatus necessary to produce
LDs as storage vesicles.
Further Comparison of Proteomic and Transcriptomic
Results after Compound Treatment with Nitrogen
Deprivation Using Published Data
To further compare and contrast alterations in the
proteomic and transcriptomic profiles of Chlamydomo-
nas after treatment with either compound and the
nitrogen starvation response, we compared results
from this study with assessment of protein levels after
nitrogen starvation previously reported by this lab
(Wase et al., 2014) and transcript levels from the work
of Miller et al. (2010). In making these comparisons,
it must be kept in mind that there are significant
differences in experimental conditions for each study,
including for example, length of treatment (72-h com-
pound treatment and 48-h nitrogen starvation), as well
as different controls employed (addition of vehicle in
the case of the compounds versus nitrogen-replete
media for the starvation experiments) and different
analytical methods. For this illustrative assessment, the
raw transcript data available in published archives was
employed in the comparative analyses. For comparison
of protein expression, the results of the analyses were
used after processing because the raw data files were
acquired using different analytical methods. The results
of the proteomics comparisons can be found in
Supplemental Dataset S14 and the transcriptomics data
comparisons in Supplemental Dataset S15. The
methods of analyses are detailed in Supplemental
Methods S1.
For treatment with WD30030 or WD10784, 747 pro-
teins were identified and quantified with at least two
peptides, whereas in the nitrogen starvation study of
Wase et al. (2014), 794 proteins were identified and
quantified, of which 572 were identified with two
peptides. Only proteins that were common to both
studies were considered for comparison here. For
WD30030 treatment, 45 proteins were increased in a-
bundance; 55 proteins were increased by WD10784;
and 18 were increased 48 h after nitrogen starvation. A
Venn diagram illustrating these comparative results
can be found in Supplemental Figure S6. A list of spe-
cific proteins that have significantly altered abundance
after at least one of the three treatments is given in
Table 3. Only five proteins with increased abundance
were common to all treatments, whereas 33 were
shared between WD30030 and WD10784. For proteins
with significantly decreased abundance, 21 were
detected after WD30030 treatment, 44 with WD10784,
and 31 after nitrogen starvation. Of these, 17 were
common to both compound treatments and only two to
the compounds and nitrogen starvation. Among the
unique expression patterns distinguishing compound
treatments from nitrogen limitations is RPE1 of the
oxidative pentose phosphate pathway (OPPP) that was
reduced by either compound treatment but not signif-
icantly different after nitrogen starvation. As men-
tioned above, CIS1 was increased in all treatments,
possibly contributing acetyl-CoA for FA synthesis. Of
three photosynthetic proteins, all were significantly
reduced by nitrogen starvation but none were sig-
nificantly changed after treatment with either
lipid-inducing compound. These data, while limited,
further support the unique impacts of WD30030 and
WD10784 compared with nitrogen starvation response.
To assess similarities and differences in the effect of
treatment with either chemical inducer and nitrogen
limitation on gene expression, a total of 15,965 tran-
scripts common to all treatment conditions were com-
pared (Supplemental Dataset S15; Supplemental Fig.
S7). These analyses demonstrated striking contrasts as
well. Treatment with WD30030 and WD10784 resulted
in 666 transcripts in common that were increased in a-
bundance and 588 transcripts in common with reduced
abundance. In contrast, few of these changes were
shared with nitrogen limitation: 125 transcripts were
increased in expression, whereas 48 were reduced un-
der all three treatment conditions. KEGG enrichment
analysis further pointed to unique transcriptomic pro-
files. Of the top-30 pathways identified as significantly
altered during treatment, 16 were increased byWD30030
treatment, 20 by WD10784 treatment, and only five by
nitrogen deprivation (Supplemental Dataset S15). Re-
duction of transcripts encoding pathway components of
the categories “photosynthetic antenna proteins,”
“photosynthesis,” “metabolic pathways,” and “DNA
replication” were the top four altered in nitrogen
deprivation. For either compound treatment, reduc-
tion in components of the pathway category “ribo-
some” ranked first, followed by the pathway
categories “endocytosis,” “DNA replication,” and the
“proteasome,” each of which increased. These dif-
ferences in transcript abundance after treatment fur-
ther support unique and extensive differences in
impact from either compound treatment (WD10784
or WD30030) versus nitrogen deprivation.
DISCUSSION
This study was conducted to define similarities and
differences in the metabolic response of Chlamydomonas
to WD30030 and WD10784 treatments that occur co-
incident with induction of lipid synthesis and storage.
The small compound inducers can be compared with
drugs that are administered to induce a specific phe-
notype, but that may have additional off-target effects
that also contribute to their effectiveness and thera-
peutic application. Thus, the physiological, biochemi-
cal, and multiomics analyses reported here provide a
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comprehensive understanding of the effects of these
two compounds on Chlamydomonas during growth.
Further, we rationalized that convergence between
metabolic pathways enhanced or repressed by both
compounds would provide information on common
mechanisms leading to TAG synthesis and accumula-
tion. These data have also been compared with nutrient
deprivation conditions, notably the well-characterized
nitrogen starvation response, to determine similar or
unique pathway effects. The most important differ-
ences between nutrient deprivation responses and the
two compounds are the maintenance of growth and
photosynthetic capacity over time, whereas growth
stops within one cell doubling when an essential nu-
trient such as nitrogen is removed from the culture
media (Miller et al., 2010; Lee et al., 2012; Wase et al.,
2014; Park et al., 2015). The maintenance of growth and
photosynthesis is most apparent for cells treated with
WD30030, because after 48 h, cultures treated with
WD10784 elicit signs of stress and chlorosis coincident
with a reduction in expression of photosynthetic pro-
tein coding genes. An oversimplified interpretation of
the response of microalgae to nutrient deprivation is
that excess carbon pools are the direct result of scav-
enging cellular components (e.g. for nitrogen) to
maintain essential cellular functions, thereby generat-
ing the need to sequester the excess carbon in stor-
age compounds including starch and lipid. As shown
previously and herein, the lipid-activating compounds
do not induce the turnover of cellular proteins or
Table 3. Comparisons of the abundance of selected proteins for compound-treated cells versus nitrogen starvation based on this work (Supplemental
Dataset S14) and Wase et al. (2014)












Cre06.g264200.t1.2 Succinate dehydrogenase 2-2 SDH2 0.93 0.38 1.36 0.822 0.034 0.043
Cre02.g080200.t1.2 Transketolase TRK1 0.58 0.25 0.61 0.049 0.002 0.000
Cre12.g510650.t1.2 Fru-1,6-bisphosphatase I FBP1 1.90 1.58 0.59 0.036 0.091 0.067
Cre12.g511900.t1.2 D-Ribulose-5-P-3-epimerase RPE1 0.24 0.19 0.97 0.003 0.001 0.890
Cre12.g554800.t1.2 Phosphoribulokinase PRK1 1.21 0.54 0.63 0.491 0.072 0.031
Cre12.g526800.t1.2 6-Phosphogluconate dehydrogenase
family protein
6PGD 1.73 2.64 1.63 0.045 0.011 0.014
Cre03.g149100.t1.2 Citrate synthase 2 CIS2 1.32 1.06 0.46 0.088 0.674 0.000
Cre12.g514750.t1.2 Citrate synthase family protein 1 CIS1 1.54 2.16 1.56 0.044 0.007 0.006









10.18 14.15 4.03 0.002 0.001 0.000
Cre12.g513200.t1.2 Enolase PGH1 1.16 0.99 1.50 0.624 0.977 0.000
Fatty acid and lipid metabolism
Cre13.g577100.t1.2 Acyl carrier protein ACP2 0.69 0.63 1.23 0.165 0.102 0.323
Cre08.g359350.t1.2 Acetyl coenzyme, a carboxylase
biotin carboxylase subunit
BCR1 0.27 0.13 0.93 0.006 0.001 0.732
Cre12.g519100.t1.2 Acetyl coenzyme, a carboxylase
carboxyltransferase alpha-subunit
ACX1 0.54 0.20 1.01 0.368 0.046 0.937




3.46 5.70 1.18 0.010 0.003 0.495









2.03 3.67 2.92 0.052 0.007 0.028
Starch metabolism
Cre13.g567950.t1.2 Glc-1-P adenylyltransferase STA1 0.65 0.44 0.67 0.104 0.016 0.294
Cre03.g188250.t1.2 Glc-1-P adenylyltransferase STA6 0.72 0.36 0.55 0.287 0.020 0.117
Cre03.g181500.t1.2 Disproportionating enzyme STA11 2.41 2.23 1.74 0.021 0.028 0.535
Cre07.g336950.t1.1 Alpha-glucan phosphorylase 2 PHOA 1.86 2.86 2.74 0.033 0.005 0.000
Cre12.g552200.t1.2 Alpha-glucan phosphorylase 2 PHOB 1.40 1.82 1.14 0.173 0.044 0.131
Photosynthesis
Cre12.g550850.t1.2 PSII subunit P-1 PSBP1 0.90 0.74 0.21 0.670 0.225 0.001
Cre16.g673650.t1.1 LHC of PSII 5 IHCB5 0.98 0.77 0.19 0.907 0.179 0.000




LEU1S 2.23 3.42 0.96 0.024 0.006 NS
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membrane lipids associated with starvation stress re-
sponse (Schmollinger et al., 2014; Wase et al., 2017).
Instead, protein synthesis is maintained, amino acid
biosynthesis is potentiated, and carbon flow is directed
toward storage of only TAG (i.e. WD30030 treatment)
or both starch and TAG (i.e. WD10784). The common
pathway shifts induced by both WD10784 and
WD30030 compared to controls provide insight into
alterations in protein and metabolites that contribute to
TAG production (Fig. 9), while differences, particularly
those related to stress and starch synthesis induced by
compound WD10784, help to eliminate nonproductive
metabolic perturbations.
Central Carbon Metabolism in Compound Treatment
In Chlamydomonas, the Calvin–Benson–Bassham cy-
cle, OPPP, and glycolysis, overlap and share several
reaction steps in common, but are differentially com-
partmentalized such that the reactions of glycolysis
from Glc to G3P are localized in the plastid and the
reactions from 3-PGA to pyruvate are localized in the
cytosol (Johnson and Alric, 2013). The OPPP enzymes
Glc-6-P dehydrogenase and 6-PG dehydrogenase are
found within both compartments. Metabolite analysis
indicated elevated levels of several key intermediates
including Fru-6-P, ribulose-5-P, ribulose-1,6-bisphos-
phate, and xylulose-5-P for either compound treatments
compared with controls. PFK2 (Cre12.g553250.t1.2) reg-
ulates the conversion of Fru-6-P to Fru-1,6-bisphosphate
and when ATP concentrations are low, PFK2 is acti-
vated and enhances glycolytic flux and starch break-
down (Gibbs et al., 1986) to induce the Pasteur effect
characterized by the activation of glycolysis in response
to inhibition of mitochondrial ATP production (Rebeille
and Gans, 1988; Gans and Rebeille, 1990). In previous
work, Fru-6-P was found to be elevated 17-fold by
WD30030 treatment and 360-fold by WD108784,
whereas Fru-1,6-P levels were reduced 0.47- and
0.71-fold, respectively, most likely due to metabolic
conversion to G3P (Wase et al., 2017). G3P can provide
the backbone to glycerol lipids including storage TAG
as catalyzed by glycerol-3-P acyltransferase (PLSB). In
this studies, PFK2 levels were significantly increased at
both the protein and RNA levels, as was glyceralde-
hyde-3-P dehydrogenase (GAPDH), which catalyzes
the conversion of G3P to 3-PGA. GAPDH encoded
within GAP1a and GAP2 was highly upregulated in
Figure 9. Major changes in proteins and metabolites shared by both WD10784 and WD30030 treatments. The pathways are
simplified to emphasize major routes in central carbon metabolism leading to triglyceride and starch storage. Red, increased
abundance; green, decreased; black, no change in at least one condition; gray, not detected. For impacts of each compound on
starch and triglyceride synthesis, see Figures 4 and 5, respectively. Enzyme abbreviations: ACH, aconitate hydratase, mito-
chondrial; ACK, acetate kinase; ACL, ATP-citrate lyase; CIS, citrate synthase; DGTT1, diacylglycerol acyltransferase type 2; FBA,
fructose-1,6-bisphosphate aldolase; FBP, fructose 1,6-bisphosphatase; FUM, fumarate hydratase; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; GDH, glutamate dehydrogenase; GPD1, glycerol-3-phosphate dehydrogenase; GPM, phosphoglu-
comutase; HK, hexokinase; ICL, isocitrate lyase; IDH, isocitrate dehydrogenase; IPA1, importin subunit a; MDH: malate
dehydrogenase; MLDP, major lipid droplet protein; MS, malate synthase; OGD, oxoglutarate dehydrogenase E2 component;
PAT2, phosphotransacetylase; PCK, phosphoenolpyruvate carboxykinase; PDAT, phospholipid:diacylglycerol acyltransferase;
PDH, pyruvate dehydrogenase; PEPC, phosphoenolpyruvate carboxylase; PFK, phosphofructokinase; PGI, phosphoglucose
isomerase; PGM, phosphoglucomutase; PHOA, starch phosphorylase; PYC1, pyruvate carboxylase; SBE, starch branching en-
zyme; SDH, succinate dehydrogenase; SS1, soluble starch synthase; SSS, Starch synthase, chloroplastic/amyloplastic; STA1,2,6,
ADP-glucose pyrophosphorylase; TOM40, 40 kDa translocon at mitochondrial outer envelope membrane; TPI, triosephosphate
isomerase; VPS26, subunit of retromer complex.
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cells treated with either compound. In Chlamydomonas,
GAPDH forms a complexwith PRK1. AlthoughWD30030
had no significant effect on PRK1 abundance, the protein
level was reduced ;35% and RNA ;93% by WD10784
treatment, which may ultimately affect 3-PGA levels
available for the Calvin–Benson–Bassham cycle.
In the final reaction of glycolysis, pyruvate dehy-
drogenase catalyzes the formation of acetyl-CoA for
use in the tricarboxylic acid cycle. The abundance of this
protein was increased over time after nitrogen removal
and continued for up to 144 h and, concomitantly, py-
ruvate levels were reduced (Wase et al., 2014). Neither
WD30030 nor WD10784 affected pyruvate dehydro-
genase protein or transcript abundance, supporting the
unique impact of these compounds in preserving the
integrity of central carbon metabolism.
The amphibolic tricarboxylic acid cycle is required
both to produce energy as ATP and to supply critical
intermediates for anabolic processes including amino
acid, nucleotide, and sugar biosynthesis. Overall, there
was little impact on the expression of protein compo-
nents of the tricarboxylic acid cycle, suggesting regu-
latory impact of the compounds on this pathway most
likely occur at the level of metabolite flux. At the me-
tabolite level, the compounds elevate isocitrate, succi-
nate, and fumarate levels, concomitant with an
elevation of various amino acids that are synthesized in
anabolic reactions utilizing tricarboxylic acid cycle in-
termediates (herein and Wase et al., 2017). This gener-
ally only occurs when there is sufficient ATP and
substrates for the anabolic reactions. The increases in
ATP-isocitrate lyase and CIS were notable in that these
enzymes are critical for the formation of cytosolic
acetyl-CoA for FA biosynthesis and are only active
when ATP and citrate are abundant.
Starch biosynthesis was examined critically to help
understand why WD10784 but not WD30030 increases
this storage compound. The answer seems to lie in the
relative impact of this compound on the precursor
metabolites, as well as transcripts and proteins. G-6-P
and F-6-P levels are 15- and 20-fold higher, respectively,
when cells are treated with WD10784 relative to
WD30030. Some key proteins are also elevated including
STA2, PhoA, and PhoB. Likewise, transcripts for many
starch-synthesizing enzymes accumulate to higher levels
compared with controls. Thus, it appears the cumulative
effects of these unique patterns of change induced by
WD10784 result in elevated starch levels.
Catabolic Enzymes of Lipid Metabolism Are Maintained
or Reduced in Expression Potentiating Lipid Accumulation
Reduction in lipid degradation by lipases and FA
oxidation enzymes might also contribute to lipid ac-
cumulation and storage. Lipases and phospholipases
hydrolyze the ester bond between the acyl-chain of
TAGs or phospholipids, respectively, and the glycerol
backbone, yielding a free FA and a corresponding lyso-
lipid (Goold et al., 2015). The released acyl-chain may
be further incorporated into glycerolipids or shuttled
between the membrane lipids and TAG pool. Lipases
are also suggested to maintain the equilibrium during
continuous oil synthesis to prevent hyper-accumulation
of oil and lipotoxicity in the cell. As noted above, the
expression of at least three lipases was reduced in
compound-treated cells compared with controls. In
terms of b-oxidation enzymes, the expression of the
acyl-CoA oxidase gene encoded by ACX1 was reduced
by both compounds, whereas ACX3 protein was in-
duced by both. Enoyl-CoA hydratase1, ECH1, protein
expression was increased by WD30030 but not affected
by compound WD10784. A major reduction was ob-
served in the expression of two transcripts encoding
peroxisomal 2,4-dienoyl-CoA reductase and 3-
hydroxyisobutyryl-CoA hydrolase. Although mixed,
overall these results suggest that reductions in lipol-
ysis and/or FA oxidation are not major contributing
factors to lipid accumulation in response to either
compound.
LD Formation Is Potentiated
LD formation has been most extensively studied in
eukaryotic systems where a model has emerged in
which lipid storage molecules including TAGs are
synthesized concurrently with modification of the ER
membrane to include LD proteins (Chapman et al.,
2019). As the lipid particle expands, it is released by a
process of budding and scission. It has further been
proposed that the ARF1/COPI machinery controls the
formation of a membrane bridge between LDs and the
ER to target proteins including DGAT, glycerol-3-P
acyltransferase, and adipose triglyceride lipase to the
maturing LD (Thiam et al., 2013). Additionally, the
ARF1/COPI proteins may directly act on the LDs to
remove phospholipids from the LD surface by forming
nano-sized LDs. This is suggested to result in an in-
crease in the surface tension of the LDs and helps in
building a bridge between the LDs and the ER to
contribute to LD formation (Wilfling et al., 2014).
Both compounds induced the transcript levels of the
ADP-ribosylation factor, the coatomer subunits
COPII a, b, g, and «, and the vacuolar sorting proteins
of the VPS family and SEC31. Recently, a number of
Chlamydomonas proteins have been proposed as ho-
mologs of yeast and mammalian proteins involved in
LD dynamics (Huang et al., 2019). Five of these that
are proposed to regulate droplet fusion, lipid accu-
mulation, and maturation were increased at the
transcript level by either WD10784 or WD30030.
These include two syntaxins (Cre16.g692050 and
Cre17.g711450), one Rab GTPase (Cre15.g641800), a
Septin 9-like protein (Cre12.g556250), and, as men-
tioned, Arf1 (Cre10.g448200). Together with the in-
duction of TAG biosynthetic genes and proteins
including MLDP and DGTT1, these results support the
role for WD30030 and WD10784 in inducing LD bio-
synthesis and accumulation.
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Compound Treatment Maintains Photosynthesis
and Respiration
An essential distinction between WD30030 and
WD10784 treatment to induce lipid synthesis and nu-
trient deprivation conditions is the maintenance of
photosynthetic capacity by WD30030 relative to
WD10784. This was measured directly by assessing
photosynthetic rates and indirectly using proteomic
and transcriptomic analyses. Many proteins of PSI,
PSII, and the LHCswere identified and compared using
label-free proteomics. These data demonstrated that the
protein subunits of the complexes are largely main-
tained during compound treatment. However, at the
level of RNA, most transcripts were reduced in abun-
dance after 72 h of compound treatment, with repres-
sion of gene expression in response to WD10784 being
more severe compared with WD30030 treatment. En-
zymes of the Calvin–Benson–Bassham cycle, especially
Rubisco, are generally severely reduced in nutrient
starvation and other stresses (Longworth et al., 2012;
Schmollinger et al., 2014; Wase et al., 2014; Park et al.,
2015), whereas expression of triosephosphate isom-
erase and FBA3 are increased (Schmollinger et al.,
2014). The Rubisco small and large subunit proteins
are maintained during either compound treatment. In
contrast, the Calvin–Benson–Bassham enzymes RPE1
and TRK1 both were significantly downregulated in
both compound treatment conditions. SEBP1 was
significantly downregulated at the protein level
only during treatment with compound WD10784
(0.29-fold).
The maintenance of respiratory complex proteins
coordinated with photosynthetic proteins during com-
pound treatment, in general, suggests cellular energy
production is maintained. This is in direct contrast to
our previous findings assessing the proteome of cells
during nitrogen deprivation that demonstrated pro-
teins involved in OxPhos were significantly elevated,
whereas levels of proteins of the photosynthetic and
LHCs were reduced (Wase et al., 2017). The results in
nitrogen deprivation conditions were interpreted to
indicate that cellular metabolism was in energy deficit.
The results for treatment withWD30030 andWD10784,
in this article, are in direct contrast.
CONCLUSION
Although a specific single target of either WD30030
orWD10784 cannot be identified from these studies, the
multiomics analyses of Chlamydomonas cells grown in
the presence of these lipid-inducing small molecules
strongly support the contention that microalgae can
be induced to produce and store triglycerides in LDs
without terminating growth, or stimulating a severe
stress response, or causing destruction of thylakoid
membranes and proteins. By analogy to drugs aimed
at a therapeutic endpoint (e.g. reduction in obesity),
the importance of these results lies in the broad
understanding they provide in the shifts in algal
physiology, biochemical pathways, and metabolites
that result from compound treatment. Metabolite
analysis reported herein and previously (Wase et al.,
2017) further demonstrated that these small molecules
could be used to produce high levels of Calvin–
Benson–Bassham, glycolytic, and tricarboxylic acid
cycle intermediates, as well as amino acids and anti-
oxidant compounds to drive both growth and carbon
storage. Therefore, these compounds offer the oppor-
tunity to delve further into the metabolic shifts re-
quired to maximize lipid production as required if
microalgae are to be employed as feedstock for bio-
fuels or other high-value products. Additionally,
these results provide a database of information that
may be used to identify additional pathways and
products of interest to the research and commercial
communities. WD30030 in particular is being further
examined for industrial applications.
MATERIALS AND METHODS
Cell Culture and Compound Treatment
The Chlamydomonas reinhardtii strain CC-125 was used for all studies. Cells
were routinely maintained on TAP solid media and were used to inoculate a
liquid starter culture. The cells were routinely cultured in liquid TAP media at
25°C under constant illumination with cool-white fluorescent bulbs with a
photon flux density of 50 mmol photons m22 s21 and continuous shaking (120
rpm). For compound treatment, cells from midlog phase culture were har-
vested, washed once with fresh sterile TAP media, and inoculated at starting
density of 53 105 cells/mL. The test compoundsWD30030 andWD10784 were
then added to a final concentration of 5 mM unless otherwise stated and controls
received the vehicle dimethyl sulfoxide. Cell cultures (100 mL) were grown in
250-mLErlenmeyerflaskswith rubber stoppers adapted to facilitate gas exchange in
an Innova 43Orbital ShakingGrowthChamber (NewBrunswick) under continuous
lighting. Cell numbers were quantified using a model no. TC-10 Automated Cell
Counter (Bio-Rad). Harvesting was performed by centrifugation. Three indepen-
dent biological replicateswere employed for RNA, protein, ormetabolite extraction.
For all experiments, control cultures contained dimethyl sulfoxide instead of com-
pound. For comparison, the protein, RNA, andmetabolite data values are presented
relative to data obtained for the controls.
Statistical Analysis
Significant differences among treatment groups and controls for assessment
of growth, photosynthetic and respiration rates measurements, and GSH
and H2O2 assays were determined using either the Student’s t test or one-
way ANOVA followed by Tukey’s posthoc test. Comparison of groups over
time was carried out with mixed-model, two-way ANOVAwith Bonferroni
posttest.
Additional Methods
Additional detailed methods related to assessment of growth, photosyn-
thetic, and respiration rates measurements, GSH and H2O2 assay, proteome
analysis, mass spectrometry (MS) analysis of the peptides, data processing of
the proteomics dataset, western analysis of targeted proteins, transcriptome
analysis, gene expression by RT-qPCR, and cellular metabolite analysis by ultra
performance liquid chromatography (UPLC)-MS are available in Supplemental
Methods S1.
Accession Numbers
All original RNA-Seq data are deposited in the National Center for Bio-
technology Information BioProject database archive under accession number
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PRJNA324451 (https://www.ncbi.nlm.nih.gov/sra/?term5PRJNA324451).
Raw mass spectrometry data for label-free quantitative proteome profiling is
deposited in the Pride ProteomeXchange data repository under accession
number PXD006736 (http://www.ebi.ac.uk/pride/archive/projects/PXD006736).
Raw mass spectrometry data for untargeted LC-MS metabolomics analysis are ar-
chived in theMetabolomicsWorkbenchdatabase (http://metabolomicsworkbench.
org/) under the accession number ST000621.
Supplemental Data
The following supplemental materials are available.
Supplemental Methods. Detailed methods of data acquisition and
analysis.
Supplemental Figure S1. Differential expression analysis of proteomics
datasets.
Supplemental Figure S2. Overview of the transcriptome dataset analysis
of RNA-Seq data.
Supplemental Figure S3. KEGG enrichment analysis of differentially
expressed transcripts.
Supplemental Figure S4. Correlations between data obtained using RNA-
Seq and RT-qPCR for selected genes after each treatment.
Supplemental Figure S5. Assessment of metabolites that are significantly
increased or decreased in cells treated with either compound.
Supplemental Figure S6. Comparisons between protein abundance from
this compound treatment study and nitrogen starvation from Wase et al.
(2014) presented in Venn diagrams.
Supplemental Figure S7. Overview of the transcriptome dataset analyses
of RNA-Seq data for comparison of treatment with the two compounds
(this study) and nitrogen starvation from Miller et al. (2010).
Supplemental Dataset S1. Quantitative proteomics data and KEGG path-
way enrichment.
Supplemental Dataset S2. Transcriptomics data from RNA-Seq and KEGG
pathway analysis.
Supplemental Dataset S3. List of primers and comparison of expression of
selected target genes using RT-qPCR, RNA-Seq, and quantitative
proteomics.
Supplemental Dataset S4. Untargeted LC-MS metabolomics data.
Supplemental Dataset S5. DEGs and proteins related to central carbon
metabolism (acetate, glycolysis, Calvin–Benson–Bassham cycle, tricar-
boxylic acid cycle, and starch metabolism).
Supplemental Dataset S6. DEGs and proteins related to FA and lipid
metabolism.
Supplemental Dataset S7. DEGs and proteins related to nitrogen and
amino acid metabolism
Supplemental Dataset S8. DEGs and proteins of photosynthesis.
Supplemental Dataset S9. DEGs and proteins of respiration and oxidative
photophosphorylation.
Supplemental Dataset S10. DEGs and proteins related to redox
homeostasis.
Supplemental Dataset S11. DEGs and proteins related to ribosomes.
Supplemental Dataset S12. DEGs and proteins related to heat shock stress
and autophagy.
Supplemental Dataset S13. DEGs and proteins related to protein transport
and vesicular trafficking.
Supplemental Dataset S14. Differential protein expression patterns for
compound-treated cells or N-starved cells.
Supplemental Dataset S15. Differential transcript expression patterns for
compound-treated cells or N-starved cells.
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